Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic DDI Study of UIC202304 and UIC202305 in Healthy Volunteers
NCT07735052Phase 1Completed
- Sponsor
- Korea United Pharm Inc.
- Start
- Sep 2023
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Area Under the Plasma Concentration-Time Curve Over a Dosing Interval at Steady State at Day 16 and Maximum Plasma Concentration at Steady State at Day 16. Started Sep 2023; status: completed.
Beyond the preview
Go deeper on NCT07735052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735052.